A citation-based method for searching scientific literature

Rebecca Strawbridge, Allan H Young, Anthony J Cleare. Neuropsychiatr Dis Treat 2017
Times Cited: 106







List of co-cited articles
1063 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
20

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
12


Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Naomi R Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M Byrne, Abdel Abdellaoui, Mark J Adams, Esben Agerbo, Tracy M Air, Till M F Andlauer,[...]. Nat Genet 2018
772
12

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
11

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
253
10

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
10


Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
9

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.
Heath D Schmidt, Richard C Shelton, Ronald S Duman. Neuropsychopharmacology 2011
245
9

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
9

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
409
9

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
396
9


A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
9


Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.
F Lamers, N Vogelzangs, K R Merikangas, P de Jonge, A T F Beekman, B W J H Penninx. Mol Psychiatry 2013
361
8

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
779
8

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.
Thomas Insel, Bruce Cuthbert, Marjorie Garvey, Robert Heinssen, Daniel S Pine, Kevin Quinn, Charles Sanislow, Philip Wang. Am J Psychiatry 2010
8

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
147
8



Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
8

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
376
8

Depression: an inflammatory illness?
Rajeev Krishnadas, Jonathan Cavanagh. J Neurol Neurosurg Psychiatry 2012
205
7


The HPA axis in major depression: classical theories and new developments.
Carmine M Pariante, Stafford L Lightman. Trends Neurosci 2008
928
7


Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.
Bharathi S Gadad, Manish K Jha, Andrew Czysz, Jennifer L Furman, Taryn L Mayes, Michael P Emslie, Madhukar H Trivedi. J Affect Disord 2018
38
18

Major depressive disorder.
Christian Otte, Stefan M Gold, Brenda W Penninx, Carmine M Pariante, Amit Etkin, Maurizio Fava, David C Mohr, Alan F Schatzberg. Nat Rev Dis Primers 2016
366
7

The PHQ-9: validity of a brief depression severity measure.
K Kroenke, R L Spitzer, J B Williams. J Gen Intern Med 2001
7


Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.
Ole Köhler-Forsberg, Henriette N Buttenschøn, Katherine E Tansey, Wolfgang Maier, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer, Marcella Rietschel,[...]. Brain Behav Immun 2017
70
8

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
447
6


Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.
Yogesh Dwivedi, Hooriyah S Rizavi, Robert R Conley, Rosalinda C Roberts, Carol A Tamminga, Ghanshyam N Pandey. Arch Gen Psychiatry 2003
506
6

Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers.
Bhautesh D Jani, Gary McLean, Barbara I Nicholl, Sarah J E Barry, Naveed Sattar, Frances S Mair, Jonathan Cavanagh. Front Hum Neurosci 2015
12
50

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
6

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
722
6

Molecular biomarkers of depression.
Anand Gururajan, Gerard Clarke, Timothy G Dinan, John F Cryan. Neurosci Biobehav Rev 2016
40
15

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
Viktoria Stelzhammer, Frieder Haenisch, Man K Chan, Jason D Cooper, Johann Steiner, Hannah Steeb, Daniel Martins-de-Souza, Hassan Rahmoune, Paul C Guest, Sabine Bahn. Int J Neuropsychopharmacol 2014
61
9

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.
Floriana S Luppino, Leonore M de Wit, Paul F Bouvy, Theo Stijnen, Pim Cuijpers, Brenda W J H Penninx, Frans G Zitman. Arch Gen Psychiatry 2010
6

A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder.
Kelly Perlman, David Benrimoh, Sonia Israel, Colleen Rollins, Eleanor Brown, Jingla-Fri Tunteng, Raymond You, Eunice You, Myriam Tanguay-Sela, Emily Snook,[...]. J Affect Disord 2019
38
15

The corticosteroid receptor hypothesis of depression.
F Holsboer. Neuropsychopharmacology 2000
5

Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
763
5

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.
Enrico Domenici, David R Willé, Federica Tozzi, Inga Prokopenko, Sam Miller, Astrid McKeown, Claire Brittain, Dan Rujescu, Ina Giegling, Christoph W Turck,[...]. PLoS One 2010
217
5

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
512
5

Neuroimmune mechanisms of depression.
Georgia E Hodes, Veronika Kana, Caroline Menard, Miriam Merad, Scott J Russo. Nat Neurosci 2015
231
5




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.